Fortress Biotech, Inc. - Common Stock — 財務諸表 (NASDAQ:FBIO) | MetaTrader

チャート全体を表示 Full chart

Fortress Biotech, Inc. - Common Stock

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

ニュース

Fortress Biotech: Is It Time To Pay The Deferred Preferred Stock Dividends? (FBIO)

Avenue Therapeutics licenses ATX-04 for Pompe disease treatment

Fortress Biotech Stock: The PRV Catalyst That Could Reprice This Microcap (NASDAQ:FBIO)

Cigna Q4 Earnings Beat Estimates on Higher Specialty Volumes

Elevance Health Q4 Earnings Beat Estimates on Increasing Premiums

Centene Expands Palliative Care Access in Ohio Through Tuesday Health

FDAが小児のメンキス病に対する初の治療薬を承認

FDA approves first treatment for Menkes disease in children

フォートレス・バイオテック社のメンケス病治療薬、FDAが新たなPDUFA期日を設定

FDA sets new PDUFA date for Fortress Biotech’s Menkes disease therapy

フォートレス・バイオテック、メンケス病治療薬のNDA再申請を報告

Fortress Biotech (FBIO) Surpasses Q3 Earnings Estimates